Oncogenes and the mammalian X chromosome

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• No known oncogenes map to the mammalian X chromosome, suggesting unique regulatory mechanisms.
• Trans-acting regulation is a potential mechanism controlling oncogene expression and function.
• Chromosomal aberrations are common in tumors, but typically do not involve the X chromosome.

Purpose of the Study:

• To investigate a trans-acting regulation mechanism affecting oncogenes.
• To demonstrate a specific regulation of DNA replication timing at the c-myc gene locus in murine T-cell leukemia.
• To explore the implications of this mechanism for chromosomal regulation, particularly concerning the X chromosome.

Main Methods:

• Analysis of DNA replication timing at the putative c-myc gene locus in murine T-cell leukemia.
• Intraspecific hybridization experiments using tumor and non-tumor cells.
• Comparative analysis of chromosomal regulation between homologous loci and the X chromosome.

Main Results:

• A qualitative change in DNA replication timing at the c-myc gene locus was observed in murine T-cell leukemia.
• This change in replication timing spread to all chromosome 15 homologs in intraspecific hybrids, indicating a binary trans-acting regulation.
• The mammalian X chromosome, with its typically single active gene copy, cannot support this type of homologous locus regulation.

Conclusions:

• A binary trans-acting regulation mechanism between homologous chromosomal loci influences DNA replication timing of oncogenes.
• This mechanism is demonstrated at the c-myc locus in murine T-cell leukemia.
• The unique nature of the mammalian X chromosome (e.g., X-inactivation) precludes this specific type of homologous gene regulation, explaining its absence from oncogene mapping.